• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Enable Injections

8 drug delivery innovations you need to know

February 25, 2021 By Sean Whooley

The drug delivery space has seen plenty of innovation over the years and there are no signs of that slowing down any time soon. Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means. Among the […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Featured, Pharmaceutical Tagged With: dyvebioscience, Enable Injections, evoxtherapeutics, Inovio Pharmaceuticals, Johns Hopkins, Lyra Therapeutics, Medtronic, Tandem Diabetes Care, Teva Pharmaceuticals, Teva Respiratory

Enable Injections completes $25M credit facility

September 8, 2020 By Sean Whooley

Enable Injections announced today that it completed a credit facility worth $25 million from Oxford Finance LLC. Cincinnati-based Enable Injections said in a news release that the funds are earmarked for supporting the scaling of high-volume manufacturing and the achievement of major inflection points as it moves toward commercialization. Get the full story at our sister […]

Filed Under: Business/Financial News, Drug-Device Combinations, Funding Roundup Tagged With: Enable Injections, Oxford Finance

Enable Injections inks deal with Genentech

August 22, 2019 By Sean Whooley

Enable Injections said yesterday that it entered a developmental partnership with Genentech for the Enable enFuse device. Cincinnati-based Enable’s enFuse is an on-body drug delivery platform containing a drug transfer system compatible with syringes and vial containers. Currently, the enFuse is being developed for subcutaneous delivery of large volumes potentially rising to 50 mL. The […]

Filed Under: Drug-Device Combinations, Pharmaceutical Tagged With: Enable Injections, Genentech

Enable Injections inks deal with Sanofi for drug delivery platform

June 3, 2019 By Danielle Kirsh

Enable Injections said today that it inked a partnership with Sanofi for its enFuse drug delivery platform. Cincinnati-based Enable Injections developed the enFuse device to enable patient-administered subcutaneous delivery of high-volume therapeutics outside of the hospital. The on-body drug delivery platform has a self-contained drug transfer system that is compatible with standard syringes and vial […]

Filed Under: Drug-Device Combinations, Featured Tagged With: Enable Injections, Popular Posts, Sanofi

Enable Injections inks development deals for wearable drug-delivery device

November 13, 2018 By Sarah Faulkner

Enable Injections said today that it inked development deals with Apellis Pharmaceuticals and UCB for its enFuse on-body drug-delivery device. The Cincinnati-based company has ongoing partnerships with five companies. Enable Injection’s enFuse device is designed for the subcutaneous delivery of high-volume drugs, including monoclonal antibodies. Get the full story at our sister site, Drug Delivery Business […]

Filed Under: Drug-Device Combinations, Pharmaceutical Tagged With: Enable Injections

Sanofi leads $50m round for Enable Injections’ on-body drug-delivery platform

October 29, 2018 By Sarah Faulkner

Enable Injections said last week that it closed a $50 million Series B round, led by Sanofi (NYSE:SNY), to fund the development of its enFuse on-body drug-delivery system. Previous investors, including the Cleveland Clinic and CincyTech, and private investors also participated in the round. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Drug-Device Combinations, Funding Roundup, Pharmaceutical Tagged With: Enable Injections, Sanofi-Aventis

How Enable Injections plans to bring value to pharma with its drug-delivery device

November 27, 2017 By Sarah Faulkner

Mike Hooven is no stranger to the medical device industry – he has spent the last 30 years launching companies and developing technologies for a variety of clinical applications. So when he ventured into drug delivery, he knew that he needed to find out what people in the pharmaceutical industry needed. A number of executives […]

Filed Under: Drug-Device Combinations, Pharmaceutical Tagged With: Enable Injections

Meet 5 companies developing novel drug-delivery devices

October 26, 2017 By Sarah Faulkner

At the 7th annual Partnership Opportunities in Drug Delivery event, presented by The Conference Forum, device companies gathered to tout their drug-delivery technologies and learn from each other’s mistakes and successes. Among them were needle-free injectors, patch pumps, auto-injectors and other novel delivery devices. Moderated by Pfizer‘s (NYSE:PFE) senior director of device strategy, Mathias Romacker, companies including Insulet (NSDQ:PODD), West Pharmaceutical […]

Filed Under: Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: becton dickinson, Bespak, Enable Injections, Insulet, West Pharmaceutical Services Inc.

Enable Injections launches 1st multi-vial/syringe biologics delivery system

June 20, 2017 By Sarah Faulkner

Enable Injections Inc. launched a new single, partial or multi-vial/syringe transfer system used to fill its large volume wearable injectors. The system enables patients to either use multiple vials or syringes to deliver biologics and high volume drugs subcutaneously. The hand-held transfer system can work with any pharmaceutical primary container closure, Enable Injections said, and […]

Filed Under: Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: Enable Injections

Enable Injections lands $30m Series A for large-volume injector

October 5, 2016 By Sarah Faulkner

Enable Injections Inc. said today that it closed a $30 million Series A round to bring its large-volume injector to market. The Cincinnati, Ohio-based company’s Enable Injector adheres to a patient’s body and delivers biologic doses as large as 50 milliliters. It can be used at work or at home, providing an alternative to costly […]

Filed Under: Drug-Device Combinations, Funding Roundup Tagged With: Enable Injections

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS